| Crystal Structure of Human Glycolate Oxidase (GO) in Complex with CDST | | homo-4-mer | 1-363 | 4×FMN; 4×2RD; |
| Assess |
| 1.2 A resolution structure of human hydroxyacid oxidase 1 bound with FMN and 4-carboxy-5-[(4-chloro… | | homo-4-mer | 1-362 | 16×EDO; 4×FMN; 4×C7C; |
| Assess |
| Structure of human hydroxyacid oxidase 1 bound with FMN and glycolate | | homo-4-mer | 1-362 | 16×EDO; 4×PG4; 4×FMN; 4×GOA; |
| Assess |
| Crystal structure of HAO1 in complex with indazole acid inhibitor - compound 5 | | homo-4-mer | 1-362 | 4×FMN; 4×SL7; |
| Assess |
| Crystal structure of HAO1 in complex with biaryl acid inhibitor - compound 3 | | homo-4-mer | 3-363 | 4×SLG; 4×FMN; |
| Assess |
| Structure of human hydroxyacid oxidase 1 bound with 5-bromo-N-methyl-1H-indazole-3-carboxamide | | homo-4-mer | 2-362 | 4×EDO; 4×7RI; 4×FMN; |
| Assess |
| Structure of human hydroxyacid oxidase 1 bound with 6-amino-1-benzyl-5-(methylamino)pyrimidine-2,4(… | | homo-4-mer | 3-362 | 4×FMN; 4×I2Z; |
| Assess |
| Structure of human hydroxyacid oxidase 1 bound with 2-((4H-1,2,4-triazol-3-yl)thio)-1-(4-(3-chlorop… | | homo-4-mer | 3-362 | 4×I2W; 4×FMN; |
| Assess |
| Crystal structure of HAO1 in complex with indazole acid inhibitor - compound 4 | | homo-4-mer | 3-362 | 4×FMN; 4×SLJ; |
| Assess |
| Crystal Structure of Human Glycolate Oxidase in Complex with Glyoxylate | | homo-4-mer | 3-362 | 4×FMN; 4×GLV; |
| Assess |
| Crystal Structure of Human Glycolate Oxidase in Complex with Sulfate | | homo-4-mer | 4-362 | 4×SO4; 4×FMN; |
| Assess |
| CRYSTAL STRUCTURE OF HUMAN GLYCOLATE OXIDASE IN COMPLEX WITH THE INHIBITOR 5-[(4-CHLOROPHENYL)SULFA… | | homo-4-mer | 5-363 | 4×C7C; 4×FMN; |
| Assess |
| Crystal structure of Human Glycolate Oxidase with Inhibitor Compound 15 | | monomer | 1-363 | 1×FMN; 1×YOJ; 4×EDO; 3×PEG; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FMN; 1×GWS; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FMN; 1×GWG; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FMN; 1×GWV; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FMN; 1×GX4; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FMN; 2×GWP; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FMN; 1×GWY; |
| Assess |
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 4-362 | 1×FNR; 1×GX7; |
| Assess |
| Crystal structure of human hydroxyacid oxidase 1 | | monomer | 4-361 | 1×FMN; 1×GLV; |
| Assess |